Delivery Order SPE2DB20D3103-SPE2DB24FN0G6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,011.70 firm fixed-price delivery order is for the supply of 24,000 units of the prescription medication PERTZYE DR 24,000 UNIT CAPSULE. The contract has an ultimate completion date of April 18, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,179.36 firm fixed price delivery order (SPE2DB20D3101|SPE2DB24FRBB8) is for the supply of 16,000 units of PERTZYE DR 100S capsules. The contract has a completion date of February 9, 2024 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999...
- This federal contract award, valued at $7,961.40, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 24,000 units of the pharmaceutical product PERTZYE DR 24,000 UNIT CAPSULE UU 80S. This delivery order contract, with a final completion date of October 9, 2024, is a firm-fixed-price contract. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical supplies and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,242.46, is for the delivery of 24,000 units of the prescription medication PERTZYE DR 80S. The contract is a firm fixed-price, non-set-aside award with a performance period through July 2025. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of PERTZYE DR with a ceiling value of $20,343.60. This contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 15, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 24,000 units of PERTZYE DR 24,000 UNIT CAPSULE UU 80S, a pharmaceutical product. The contract has a firm fixed price of $7,757.79 and an ultimate completion date of June 26, 2025. The contract is not set aside and was awarded on June 25, 2025. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 24,000 unit capsules of the drug Pertzye, with a ceiling value of $9,416.10 and a completion date of February 5, 2025. The contract is a firm fixed-price delivery order, and there was no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $4,464.24 firm fixed price delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye on June 9, 2025, with an ultimate completion date of June 10, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $5,094.25 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, identified as SPE2DB22D3004|SPE2DB24FRM37, is for the supply of 24,000 units of the pharmaceutical product Pertzye DR 80 mg capsule. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds multiple Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 16,000 units of the pharmaceutical product Pertzye DR Capsule, with a total ceiling value of $23,802.53. The delivery order has a firm fixed price pricing type and is set to be completed by February 9, 2024. This award is not designated with any set-aside requirements, indicating full and open...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN0G6Delivery Order
This federal contract award is for the delivery of 16,000 units of the medication PERTZYE DR 16,000 UNIT CAPSULE to the Defense Logistics Agency (DLA), a defense agency. The $26,094.23 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 13, 2024, with a completion date of March 14, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 3/13/24 |